_____________________
Presentation
The “Biotherapies – Biotherapies by nucleic acid vectorization” team is developing 3 main lines of research:
* Development of innovative strategies for RNA delivery, small interfering RNAs or mRNAs.
* Pharmacological evaluation of new therapeutic strategies, mainly in the fields of inflammatory diseases, hepatic fibrosis and cancer. fibrosis or cancer.
* Development of tumor-penetrating and tumor-interfering peptides (TP and IP), capable of specifically penetrating tumor cells, without any effect on healthy cells, and blocking the interaction between two proteins deregulated during tumor transformation.
Thesis defense at UTCBS: Marion HECKMANN
On October 24, 2024, Marion Heckmann successfully defended her PhD thesis, entitled “Purification and characterization of hypertrophied hepatic stellate cells in a murine model of metabolic hepatic fibrosis”, under the supervision of Dr Virginie Escriou and Dr Céline...
UTCBS takes part in sfnano2024 conference
UTCBS takes part in sfnano2024 conference
Thesis defense at UTCBS: Monica Swetha Bosco “Fingerprint Approach Using Macrocyclic Chemical Nose Sensors for Disease Diagnostics”
Thesis defense at UTCBS: Monica Swetha Bosco “Fingerprint Approach Using Macrocyclic Chemical Nose Sensors for Disease Diagnostics”
Thesis defense at UTCBS: Nasir Arafath “Functionalization and Evaluation of Antioxidant Cerium Oxide Nanoparticles for Stroke Treatment.
Thesis defense at UTCBS: Nasir Arafath